EastWest Bioscience (EAST:TSXV) is a vertically integrated wellness company with a multitude of business units and assets that allow for a seed-to-sale supply chain management. We source our raw material, process, manufacture, test, brand, market, and distribute our products to our customers in Canada, the United States, and beyond.

EWBS_Services-Graphic-v4-04

EastWest Bioscience Business Units

Press Releases

January 6, 2021

EastWest Announces Resignation of CFO and Appointment of Interim CFO

PENTICTON, BC, January 6, 2021 – EastWest Bioscience Inc. (“EastWest” or the “Corporation“) announces that the Corporation has appointed Ciska Asriel to serve as interim Chief […]
January 4, 2021

Default Announcement

VANCOUVER, BC, January 4, 2021 – EastWest Bioscience Inc. (“EastWest” or the “Corporation“) provides this default announcement indicating EastWest’s failure to file its interim financial statements […]
December 29, 2020

Eastwest Files Audited Annual Financial Statements and Provides Second Bi-weekly Status Report Regarding Management Cease Trade Order

VANCOUVER, BC / ACCESSWIRE / December 29, 2020 / Eastwest Bioscience Inc. (“Eastwest” or the “Corporation“) announces that it filed its annual consolidated financial statements for the […]
December 14, 2020

Eastwest Issues Bi-weekly Status Report Regarding Management Cease-Trade Order

VANCOUVER, BC / ACCESSWIRE / December 14, 2020 / Eastwest Bioscience Inc. (TSXV:EAST)(“Eastwest” or the “Corporation“) provides this bi-weekly default status report in accordance with National Policy […]